1 |
熊 锋,娄建丽. 慢性阻塞性肺疾病急性加重期预后的临床分析[J/CD]. 中华肺部疾病杂志(电子版), 2023, 16(4): 550-553.
|
2 |
Ritchie AI, Wedzicha JA. Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations[J]. Clin Chest Med, 2020, 41(3): 421-438.
|
3 |
Sim YS, Lee JH, Lee EG, et al.COPD exacerbation-related pathogens and previous COPD treatment[J]. J Clin Med, 2022, 12(1): 111.
|
4 |
Jo YS, Han S, Lee D, et al. Development of a daily predictive model for the exacerbation of chronic obstructive pulmonary disease[J]. Sci Rep, 2023, 13(1): 18669.
|
5 |
Xiao M, Wang X, Wang H, et al. Risk factors for hyponatremia in acute exacerbation chronic obstructive pulmonary disease (AECOPD): a multicenter cross-sectional study[J]. BMC Pulm Med, 2023, 23(1): 39.
|
6 |
Potasso L, Sailer CO, Blum CA, et al. Mild to moderate hyponatremia at discharge is associated with increased risk of recurrence in patients with community-acquired pneumonia[J]. Eur J Intern Med, 2020, 75: 44-49.
|
7 |
Ni Y, Zhong H, Gu Y, et al. Clinical features, treatment, and outcome of psittacosis pneumonia: A multicenter study[J]. Open Forum Infect Dis, 2023, 10(2): 518.
|
8 |
García-Sanz MT, Martínez-Gestoso S, Calvo-Álvarez U, et al. Impact of hyponatremia on COPD exacerbation prognosis[J]. J Clin Med, 2020, 9(2): 503.
|
9 |
慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2017年更新版)[J]. 国际呼吸杂志,2017, 37(14): 1041-1057.
|
10 |
张劭夫. 2014欧洲低钠血症诊疗临床实践指南解读[J]. 中国呼吸与危重监护杂志,2015, 14(1): 103-106.
|
11 |
王 妍,闫 巍,柯 楠. 慢性阻塞性肺疾病前期特征、潜在诊断方法及干预策略[J]. 实用心脑肺血管病杂志,2023, 31(10): 1-5.
|
12 |
Li S, Huang Q, Nan W, et al. Association between serum phosphate and in-hospital mortality of patients with AECOPD: A retrospective analysis on eICU database[J]. Heliyon, 2023, 9(9): e19748.
|
13 |
Pratt AJ, Purssell A, Zhang T, et al. Complexity in clinical diagnoses of acute exacerbation of chronic obstructive pulmonary disease[J]. BMC Pulm Med, 2023, 23(1): 298.
|
14 |
Bräunlich J, Turba K, Wirtz H. Reversibility of hypercapnia after an acute exacerbation of COPD[J]. Respiration, 2022, 101(9): 816-822.
|
15 |
Guecamburu M, Coquelin A, Rapin A, et al. Pulmonary rehabilitation after severe exacerbation of COPD: a nationwide population study[J]. Respir Res, 2023, 24(1): 102.
|
16 |
Tokgöz Akyıl F, Tural Önür S, Abalı H, et al. Hyponatremia is an independent predictor of emergency department revisits in acute exacerbation of COPD[J]. Clin Respir J, 2021, 15(10): 1063-1072.
|
17 |
王 淼,汪海娅. 老年住院患者低钠血症的临床特点[J]. 上海医药,2023, 44(10): 27-30.
|
18 |
Lindner G, Herschmann S, Funk GC, et al. Sodium and potassium disorders in patients with COPD exacerbation presenting to the emergency department[J]. BMC Emerg Med, 2022, 22(1): 49.
|
19 |
张丽侠,王志芳,李 冲,等. 普通病房住院患者低钠血症及其性别、年龄特征的初步研究[J]. 临床内科杂志,2018, 35(6): 412-414.
|
20 |
Ĉiauškaitē J, Gelžinienē G, Jurkevicienē G. Oxcarbazepine and hyponatremia[J]. Medicina (Kaunas), 2022, 58(5): 559.
|
21 |
Miyauchi T, Nishiwaki H, Mizukami A, et al. Hyponatremia and mortality in patients undergoing maintenance hemodialysis: Systematic review and meta-analysis[J]. Semin Dial, 2023, 36(4): 303-315.
|
22 |
吴琪茵,胡妙芬,黄雅萍,等. 探讨高血压对慢性阻塞性肺疾病急性加重患者发生低钠血症的影响[J]. 中外医疗,2022, 41(28): 1-4.
|
23 |
Deep A, Behera PR, Subhankar S, et al. Serum electrolytes in patients presenting with acute exacerbation of chronic obstructive pulmonary disease (COPD) and their comparison with stable COPD patients[J]. Cureus, 2023, 15(4): e38080.
|
24 |
Che L, Song W, Zhang Y, et al. A randomized, double-blind clinical trial to evaluate the blood pressure lowing effect of low-sodium salt substitution on middle-aged and elderly hypertensive patients with different plasma renin concentrations[J]. J Clin Hypertens (Greenwich), 2022, 24(2): 140-147.
|
25 |
Sun Y, Wang H, Liang H, et al. A Method for estimating 24-hour urinary sodium excretion by casual urine specimen in Chinese hypertensive patients[J]. Am J Hypertens, 2021, 34(7): 718-728.
|
26 |
Knightly R, Milan SJ, Hughes R, et al. Inhaled magnesium sulfate in the treatment of acute asthma[J]. Cochrane Database Syst Rev, 2017, 11(11): CD003898.
|
27 |
Jahanian F, Khatir IG, Ahidashti HA, et al. The effect of intravenous magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in the emergency department: A double-blind randomized clinical trial[J]. Ethiop J Health Sci, 2021, 31(2): 267-274.
|
28 |
Pogozheva AV, Kodentsova VM, Sharafetdinov KK. [The role of magnesium and potassium in preventive and therapeutic nutrition][J]. Vopr Pitan, 2022, 91(5): 29-42.
|
29 |
Ni H, Aye SZ, Naing C. Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease[J]. Cochrane Database Syst Rev, 2022, 5(5): CD013506.
|